Ritolukast
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161554This classification denotes an anti-asthmatic agent with the molecular formula C17H13F3N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0E8R4GDE2Q, chemically known as 1,1,1-trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide but generally known as ritolukast, which bears US NIH Compound Identifier 60539. European Medicines Agency schedules Ritolukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10341MIG. The term RITOLUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). Most nations schedule ritolukast under HS 29350090 and SITC 51580. As of Q4 2014, RITOLUKAST remains the US FDA Preferred Term for this commodity. Ritolukast bears US NLM identifiers UMLS ID C2347965 and NCI Concept Code C74129. SMILES: S(=O)(=O)(NC1CC(OCC2NC3C(CC2)CCCC3)CCC1)C(F)(F)F.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.